“The most competitive pharma companies in the coming decade will be masters of data and digital technologies.” So begins the June 2017 industry brief, “Reinventing the Role of Medical Affairs,” by Bain & Company.
It is with great excitement that we announce that Nordic Capital has entered into a definitive agreement to acquire ArisGlobal. Over these 32 years, ArisGlobal has built a sustainable and growing business that thrives on its partnerships with many life sciences companies and regulatory agencies. These customer relationships, some lasting decades, have allowed ArisGlobal to become a leading healthcare technology company with over 1200 employees across an expansive global footprint.
The ArisGlobal marketing department spent time with Clint Wolfe, Chief Human Resources Officer. They discussed changes at ArisGlobal, working from home, how different areas of the globe are handling COVID-19 differently, and more.
When saddled with legacy medical information systems, Medical Affairs teams ...
Every one of us at some point will take a ...
Data is the lifeblood of businesses today. Data informs strategy ...
A key offering in ArisGlobal’s LifeSphere platform, LifeSphere Reporter empowers field reps, provides fields teams and approved users with secure access, and easily integrates with LSMV10 and other systems.
ArisGlobal, part of the more cautious and highly regulated life science go “all-in on AWS” by moving the entire cloud infrastructure to the AWS platform. This move benefits both ArisGlobal and to our customers.
This is the fourth in a four-part blog series that examines the Clinical, Medical Affairs, Regulatory, and Safety business units at ArisGlobal. Director of Product Management – Medical Affairs and Quality, Sandeep Mahagaonkar, spoke about what attracted him to ArisGlobal, the state of Medical Affairs, and the vision for 2020 and beyond.
Many life sciences companies are still utilizing a manual process for their medical affairs needs. ArisGlobal’s LifeSphere ® Medical Affairs platform can help automate this process. Learn more about Medical Affairs and automated processes with our webinar, Optimizing Adverse Event Reconciliation in Medical Affairs.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved